Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 03, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Metolazone Tablets USP 2.5 mg, 5 mg, and 10 mg.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 03, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Metolazone Tablets USP 2.5 mg, 5 mg, and 10 mg.".